Messages in brief

News

Revision of the EMA “Guideline on the non-clinical requirements for radiopharmaceuticals”

messages in brief | 23/04/2019
The purpose of the ‚Draft guideline on the non-clinical requirements for radiopharmaceuticals‘ (EMA/CHMP/SWP/686140/2018) is to provide guidance on…
Revision of the EMA “Guideline on the non-clinical requirements for radiopharmaceuticals” Read more
News

Revision of the EMA “Guideline on the environmental risk assessment (ERA) of human medicines”

messages in brief | 04/02/2019
The EMA published a revision of the “Guideline on the environmental risk assessment (ERA) of human medicines” on 30 November 2018. The guideline is…
Revision of the EMA “Guideline on the environmental risk assessment (ERA) of human medicines” Read more
News

New guideline on assessment and control of mutagenic impurities in veterinary medicinal products

messages in brief | 04/02/2019
In December 2018 the Committee for Medicinal Products for Veterinary Use (CVMP) adopted a guideline on the assessment and control of DNA reactive…
New guideline on assessment and control of mutagenic impurities in veterinary medicinal products Read more
News

National Immunization Schedule 2019

messages in brief | 04/02/2019
The National Immunization Schedule 2019 ("Österreichischer Impfplan") is now available.
link: https://www.sozialministerium.at/site/Gesundheit/Kran…
National Immunization Schedule 2019 Read more
News

German and Austrian drug agencies intensify cooperation on regulation of allergen products

messages in brief | 22/01/2019

A team from the Austrian Federal Office for Safety in Health Care (BASG) was a guest at the Paul Ehrlich Institute (PEI) on Jan. 14, 2019. The aim was…

German and Austrian drug agencies intensify cooperation on regulation of allergen products Read more
News

Falsification suspicion of parallel-imported "ALIMTA 500 mg powder for the preparation of a concentrate for infusion solution".

Safety warnings | messages in brief | 21/12/2018

Situation in Austria The Federal Office for Safety in Health Care (BASG) has received information that several packages of the drug "ALIMTA 500 mg…

Falsification suspicion of parallel-imported "ALIMTA 500 mg powder for the preparation of a concentrate for infusion solution". Read more
News

Changes in the declaration procedure for the medical device levy 2018

messages in brief | 19/12/2018

The procedure for declaring duties for the year 2018 will change fundamentally as of 01.01.2019. As of this date, the self-declaration must be…

Changes in the declaration procedure for the medical device levy 2018 Read more
News

Fluoroquinolones: restrictions on use

Safety warnings | messages in brief | 30/11/2018

Action at EU level The European Medicines Agency (EMA) has scientifically reassessed the serious, disabling and potentially permanent side effects of…

Fluoroquinolones: restrictions on use Read more
Email

Further inquiry note